Fujian Cosunter Pharmaceutical Hits Day Low Amid Price Pressure at CNY 120.22

Fujian Cosunter Pharmaceutical Co., Ltd. experienced a notable decline today, with the stock dropping by 3.86% on May 25, 2026. The stock reached an intraday low of CNY 120.22, reflecting a challenging trading environment. In terms of performance metrics, the company has shown a mixed trajectory over various time frames. While it has achieved a remarkable 309.1% increase over the past year, its recent one-day and one-week performances have been less favorable, with declines of 3.86% and 1.11%, respectively. The stock's year-to-date performance stands at 35.69%, significantly outperforming the China Shanghai Composite, which has gained only 4.63% during the same period. Fujian Cosunter operates within the Pharmaceuticals & Biotechnology sector and holds a market capitalization of CNY 16,311 million. Despite its substantial growth over the long term, the company faces challenges, including operating losses and a low return on equity of -96.35%. The stock's high price-to-book ratio of 64.83 further indicates potential valuation concerns. Overall, the current trading activity highlights the complexities surrounding Fujian Cosunter's market position.